Publication Cover
Endothelium
Journal of Endothelial Cell Research
Volume 2, 1994 - Issue 2
8
Views
4
CrossRef citations to date
0
Altmetric
Original Article

In Vitro Inhibitory Effect of Docosahexaenoic and Eicosapentaenoic Acids on Human Endothelial Cell Production of Interleukin-6

, , , , , , & show all
Pages 183-190 | Received 05 Apr 1994, Published online: 13 Jul 2009
 

Abstract

The interaction between lymphocytes, cytokines, and endothelial cells (EC) is a key step in the inflammatory process. Interleukin-6 (IL-6), a pleiotropic cytokine in its effects, seems to be an early indicator of acute systemic inflammation. We examined the effects of polyunsaturated fatty acids (PUFA) on the production of IL-6 by human unstirnulated EC and by EC stimulated with TNF-α (100U/ml), IL-4 (100U/ml), LPS (1 μg/ml), or allogeneic peripheral blood lymphocytes (PBL). Immunoreactive IL-6 of twenty-four hour culture Supernatants was measured by sandwich ELISA. We demonstrated that the production of IL-6 was potentiated when EC were stimulated with TNF-α, IL-4, LPS, or monocyte-depleted PBL in comparison to unstimulated EC. The addition of n-3 PUFA to the culture medium (100 pglml DHA or EPA) significantly reduced the production of IL-6 by unstimulated EC and by EC stimulated with TNF-α, IL4, LPS or depleted PBL, whereas the n-6 PUFA (Arachidonic acid), even used at a similar concentration, was ineffective. This inhibitory effect was PUFA dose-dependent. Regardless of the mode of action, these results suggest that n-3 PUFA have a role in suppressing inflammation. Further studies are needed to elucidate the mechanism involved and the choice between the two fatty acids for clinical and therapeutic purposes.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.